PROK PROKIDNEY CORP revenue, earnings and financials
For the quarter ended June 30, 2026, PROKIDNEY CORP reported revenue of $150K (down 32.1% from a year earlier), net income of −$28.4M and diluted EPS of n/a; over the last four quarters revenue was $818K and net income −$84.2M; for the fiscal year ended December 2025 revenue was $893K, up 1075.0% on the year before.
PROK annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $893K, gross profit n/a, operating income −$165M, net income −$69.0M (margin -7725.2%), EPS n/a
- Fiscal year ended Dec 2024: revenue $76.0K, gross profit n/a, operating income −$184M, net income −$61.2M (margin -80507.9%), EPS n/a
- Fiscal year ended Dec 2023: revenue $0, gross profit n/a, operating income −$152M, net income −$35.5M (margin n/a), EPS n/a
- Fiscal year ended Dec 2022: revenue $0, gross profit n/a, operating income −$153M, net income −$148M (margin n/a), EPS −$0.23
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$55.1M, net income −$55.1M (margin n/a), EPS n/a
PROK quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $150K (down 32.1% year over year), net income −$28.4M, EPS n/a
- Quarter ended Mar 31, 2026: revenue $226K (down 1.7% year over year), net income −$20.0M, EPS n/a
- Quarter ended Dec 31, 2025 (from the annual report): revenue $225K (up 196.1% year over year), net income −$19.2M, EPS n/a
- Quarter ended Sep 30, 2025: revenue $217K, net income −$16.5M, EPS n/a
- Quarter ended Jun 30, 2025: revenue $221K, net income −$16.6M, EPS n/a
- Quarter ended Mar 31, 2025: revenue $230K, net income −$16.7M, EPS n/a
- Quarter ended Dec 31, 2024 (from the annual report): revenue $76.0K, net income −$21.3M, EPS n/a
- Quarter ended Sep 30, 2024: revenue $0, net income −$17.9M, EPS n/a
- Quarter ended Jun 30, 2024: revenue $0, net income −$12.5M, EPS n/a
- Quarter ended Mar 31, 2024: revenue $0, net income −$9.49M, EPS n/a
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$5.70M, EPS n/a
- Quarter ended Sep 30, 2023: revenue n/a, net income −$11.0M, EPS n/a
- Quarter ended Jun 30, 2023: revenue n/a, net income −$9.12M, EPS n/a
- Quarter ended Mar 31, 2023: revenue n/a, net income −$9.67M, EPS n/a
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$112M, EPS n/a
- Quarter ended Sep 30, 2022: revenue n/a, net income −$29.9M, EPS n/a
- Quarter ended Jun 30, 2022: revenue n/a, net income −$2.27M, EPS n/a
- Quarter ended Mar 31, 2022: revenue n/a, net income −$3.98M, EPS n/a
- Quarter ended Sep 30, 2021: revenue n/a, net income −$252K, EPS n/a
- Quarter ended Jun 30, 2021: revenue n/a, net income −$143, EPS $0.00
PROK cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$120M, share buybacks $0
- Fiscal year ended Dec 2024: operating cash flow −$126M, share buybacks $0
- Fiscal year ended Dec 2023: operating cash flow −$90.1M, share buybacks $9.50M
- Fiscal year ended Dec 2022: operating cash flow −$77.1M, share buybacks $0
- Fiscal year ended Dec 2021: operating cash flow −$50.3M, share buybacks $0
PROK balance sheet
- Jun 30, 2026: cash $74.9M, total assets $249M, total liabilities $26.2M, shareholders' equity −$884M
- Mar 31, 2026: cash $102M, total assets $293M, total liabilities $29.7M, shareholders' equity −$1.02B
- Dec 31, 2025: cash $109M, total assets $336M, total liabilities $34.8M, shareholders' equity −$1.01B
- Sep 30, 2025: cash $95.3M, total assets $352M, total liabilities $33.3M, shareholders' equity −$1.01B
- Jun 30, 2025: cash $84.9M, total assets $372M, total liabilities $32.7M, shareholders' equity −$1.00B
- Mar 31, 2025: cash $97.8M, total assets $406M, total liabilities $36.1M, shareholders' equity −$999M
- Dec 31, 2024: cash $99.1M, total assets $441M, total liabilities $39.4M, shareholders' equity −$995M
- Sep 30, 2024: cash $108M, total assets $475M, total liabilities $31.3M, shareholders' equity −$980M
What is PROK's revenue?
PROKIDNEY CORP reported $818K of revenue over its last four quarters, through June 30, 2026.
Is PROK profitable?
No. PROKIDNEY CORP lost $84.2M over the last four quarters.